Turnstone Biologics Corp.Turnstone Biologics Corp.Turnstone Biologics Corp.

Turnstone Biologics Corp.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.78USD
Revenue estimate
Market capitalization
‪63.83 M‬USD
−2.41USD
‪−55.20 M‬USD
‪19.31 M‬USD
‪13.23 M‬
Beta (1Y)
6.78

About Turnstone Biologics Corp.

CEO
Sammy J. Farah
Headquarters
La Jolla
Employees (FY)
80
Founded
2015
FIGI
BBG011J1H914
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TSBX is 2.76 USD — it has decreased by 4.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Turnstone Biologics Corp. stocks are traded under the ticker TSBX.
Turnstone Biologics Corp. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
TSBX stock is 10.95% volatile and has beta coefficient of 6.78. Check out the list of the most volatile stocks — is Turnstone Biologics Corp. there?
TSBX earnings for the last quarter are −1.00 USD per share, whereas the estimation was −0.67 USD resulting in a −50.38% surprise. The estimated earnings for the next quarter are −0.86 USD per share. See more details about Turnstone Biologics Corp. earnings.
Yes, you can track Turnstone Biologics Corp. financials in yearly and quarterly reports right on TradingView.
TSBX stock has risen by 2.99% compared to the previous week, the month change is a 1.47% rise, over the last year Turnstone Biologics Corp. has showed a 75.79% decrease.
TSBX net income for the last quarter is ‪−16.45 M‬ USD, while the quarter before that showed ‪−17.32 M‬ USD of net income which accounts for 5.02% change. Track more Turnstone Biologics Corp. financial stats to get the full picture.
Today Turnstone Biologics Corp. has the market capitalization of ‪63.83 M‬, it has increased by 4.29% over the last week.
No, TSBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TSBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Turnstone Biologics Corp. stock right from TradingView charts — choose your broker and connect to your account.
TSBX reached its all-time high on Jul 31, 2023 with the price of 13.20 USD, and its all-time low was 1.63 USD and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has 80.00 employees. See our rating of the largest employees — is Turnstone Biologics Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Turnstone Biologics Corp. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Turnstone Biologics Corp. stock shows the strong sell signal. See more of Turnstone Biologics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Turnstone Biologics Corp. future price: according to them, TSBX price has a max estimate of 20.00 USD and a min estimate of 6.00 USD. Read a more detailed Turnstone Biologics Corp. forecast: see what analysts think of Turnstone Biologics Corp. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Turnstone Biologics Corp. EBITDA is ‪−56.23 M‬ USD, and current EBITDA margin is −286.61%. See more stats in Turnstone Biologics Corp. financial statements.